Clinical Trials Browser

Phase 2 × Stomach Neoplasms × MK 2206 × Clear all

NCT01260701 2016-01-18

Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer

Phase 2 Completed

75 enrolled 9 charts

Gastrointestinal

Stomach Neoplasms